Neurochemical Research

, Volume 32, Issue 4–5, pp 757–773 | Cite as

Redox Regulation of Cellular Stress Response in Aging and Neurodegenerative Disorders: Role of Vitagenes

  • Vittorio Calabrese
  • Eleonora Guagliano
  • Maria Sapienza
  • Mariangela Panebianco
  • Stella Calafato
  • Edoardo Puleo
  • Giovanni Pennisi
  • Cesare Mancuso
  • D. Allan Butterfield
  • Annamaria Giuffrida Stella
Original Paper

Abstract

Reduced expression and/or activity of antioxidant proteins lead to oxidative stress, accelerated aging and neurodegeneration. However, while excess reactive oxygen species (ROS) are toxic, regulated ROS play an important role in cell signaling. Perturbation of redox status, mutations favoring protein misfolding, altered glyc(osyl)ation, overloading of the product of polyunsaturated fatty acid peroxidation (hydroxynonenals, HNE) or cholesterol oxidation, can disrupt redox homeostasis. Collectively or individually these effects may impose stress and lead to accumulation of unfolded or misfolded proteins in brain cells. Alzheimer’s (AD), Parkinson’s and Huntington’s disease, amyotrophic lateral sclerosis and Friedreich’s ataxia are major neurological disorders associated with production of abnormally aggregated proteins and, as such, belong to the so-called “protein conformational diseases”. The pathogenic aggregation of proteins in non-native conformation is generally associated with metabolic derangements and excessive production of ROS. The “unfolded protein response” has evolved to prevent accumulation of unfolded or misfolded proteins. Recent discoveries of the mechanisms of cellular stress signaling have led to new insights into the diverse processes that are regulated by cellular stress responses. The brain detects and overcomes oxidative stress by a complex network of “longevity assurance processes” integrated to the expression of genes termed vitagenes. Heat-shock proteins are highly conserved and facilitate correct protein folding. Heme oxygenase-1, an inducible and redox-regulated enzyme, has having an important role in cellular antioxidant defense. An emerging concept is neuroprotection afforded by heme oxygenase by its heme degrading activity and tissue-specific antioxidant effects, due to its products carbon monoxide and biliverdin, which is then reduced by biliverdin reductase in bilirubin. There is increasing interest in dietary compounds that can inhibit, retard or reverse the steps leading to neurodegeneration in AD. Specifically any dietary components that inhibit inappropriate inflammation, AβP oligomerization and consequent increased apoptosis are of particular interest, with respect to a chronic inflammatory response, brain injury and β-amyloid associated pathology. Curcumin and ferulic acid, the first from the curry spice turmeric and the second a major constituent of fruit and vegetables, are candidates in this regard. Not only do these compounds serve as antioxidants but, in addition, they are strong inducers of the heat-shock response. Food supplementation with curcumin and ferulic acid are therefore being considered as a novel nutritional approach to reduce oxidative damage and amyloid pathology in AD. We review here some of the emerging concepts of pathways to neurodegeneration and how these may be overcome by a nutritional approach.

Keywords

Free radicals Oxidant/antioxidant balance Stress response Heme oxygenase Alzheimer's disease 

References

  1. 1.
    Boveris A, Oshino N, Chance B (1972) The cellular production of hydrogen peroxide. Biochem J 128:617–630PubMedGoogle Scholar
  2. 2.
    McCord JM, Fridovich I (1988) Superoxide dismutase: the first twenty years (1968–1988). Free Radic Biol. Med 5:363–369PubMedCrossRefGoogle Scholar
  3. 3.
    Vina J, Borras C, Gomez-Cabrera MC, Orr WC (2006) Part of the series: from dietary antioxidants to regulators in cellular signalling and gene expression. Role of reactive oxygen species and (phyto)oestrogens in the modulation of adaptive response to stress. Free Radic Res 40:111–119PubMedCrossRefGoogle Scholar
  4. 4.
    Tabner BJ, Turnbull S, El-Agnaf O, Allsop D (2001) Production of reactive oxygen species from aggregating proteins implicated in Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases. Curr Top Med Chem 1:507–517PubMedCrossRefGoogle Scholar
  5. 5.
    Zhang K, Kaufman RJ (2006) The unfolded protein response: a stress signaling pathway critical for healthand disease. Neurology 66:S102–S109PubMedCrossRefGoogle Scholar
  6. 6.
    Maines MD (2005) The heme oxygenase system: update 2005. Antioxid Redox Signal 7:1761–1766Google Scholar
  7. 7.
    Maines MD (2005) New insights into biliverdin reductase functions: linking heme metabolism to cell signaling. Physiology 20:382–389PubMedCrossRefGoogle Scholar
  8. 8.
    Baranano DE, Rao M, Ferris CD Snyder SH (2002) Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 99:16093–16098PubMedCrossRefGoogle Scholar
  9. 9.
    Ewing JF, Maines MD (2006) Regulation and expression of heme oxygenase enzymes in aged-rat brain: age related depression in HO-1 and HO-2 expression and altered stress-response. J Neural Transm 13:439–454CrossRefGoogle Scholar
  10. 10.
    Maines MD, Ewing JF, Huang TJ, Panahian N (2001) Nuclear localization of biliverdin reductase in the rat kidney: response to nephrotoxins that induce heme oxygenase-1. J Pharmacol Exp Ther 296:1091–1097PubMedGoogle Scholar
  11. 11.
    Mancuso C, Bonsignore A, Di Stasio E, Mordente A, Motterlini R (2003) Bilirubin and S-nitrosothiols interaction: evidence for a possible role of bilirubin as a scavenger of nitric oxide. Biochem Pharmacol 66:2355–2366PubMedCrossRefGoogle Scholar
  12. 12.
    Mancuso C, Bonsignore A, Capone C, Di Stasio E, Pani G (2006) Albumin-bound bilirubin interacts with nitric oxide by a redox mechanism. Antioxid Redox Signal 8:487–494PubMedCrossRefGoogle Scholar
  13. 13.
    Kaur H, Hughes MN, Green CJ, Naughton P, Foresti R, Motterlini R (2003) Interaction of bilirubin and biliverdin with reactive nitrogen species. FEBS Lett 543:113–119PubMedCrossRefGoogle Scholar
  14. 14.
    Calabrese V, Giuffrida Stella AM, Butterfield DA, Scapagnini G (2004) Redox regulation in neurodegeneration and longevity: role of the heme oxygenase and HSP70 systems in brain stress tolerance. Antioxid Redox Signal. 6:895–913PubMedGoogle Scholar
  15. 15.
    Ohara N, Kikuchi Y, Shoji M, Naito M, Nakayama K (2006) Superoxide dismutase-encoding gene of the obligate anaerobe Porphyromonas gingivalis is regulated by the redox-sensing transcription activator OxyR. Microbiology 152:955–966PubMedCrossRefGoogle Scholar
  16. 16.
    Hausladen A, Privalle CT, Keng T, DeAngelo J, Stamler JS (1996) Nitrosative stress: activation of the transcription factor OxyR. Cell 86:719–729PubMedCrossRefGoogle Scholar
  17. 17.
    Christman MF, Storz G, Ames BN (1989) OxyR, a positive regulator of hydrogen peroxide-inducible genes in Escherichia coli and Salmonella typhimurium, is homologous to a family of bacterial regulatory proteins. Proc Natl Acad Sci USA 86:3484–3488PubMedCrossRefGoogle Scholar
  18. 18.
    Motterlini R, Green CJ, Foresti R (2002) Regulation of heme oxygenase-1 by redox signals involving nitric oxide. Antiox Redox Signal 4:615–624CrossRefGoogle Scholar
  19. 19.
    Scapagnini G, Giuffrida Stella AM, Abraham NG, Alkon D, Calabrese V (2002) Differential expression of heme oxygenase-1 in rat brain by endotoxin (LPS). In: Abraham NG et al (eds) Heme oxygenase in biology and medicine. Kluwer Academic Plenum Publisher, NY, pp 121–134Google Scholar
  20. 20.
    Calabrese V, Copani A, Testa D, Ravagna A, Spadaro F, Tendi E, Nicoletti VG, Giuffrida Stella AM (2000) Nitric oxide synthase induction in astroglial cell cultures: effect on heat shock protein 70 synthesis and oxidant/antioxidant balance. J Neurosci Res 60:613–622PubMedCrossRefGoogle Scholar
  21. 21.
    Motterlini R, Foresti R, Bassi R, Calabrese V, Clark JE, Green CJ (2000) Endothelial heme oxygenase-1 induction by hypoxia. Modulation by inducible nitric-oxide synthase and S-nitrosothiols. J Biol Chem 275:13613–13620PubMedCrossRefGoogle Scholar
  22. 22.
    Drake J, Sultana R, Aksenova M, Calabrese V, Butterfield DA (2003) Elevation of mitochondrial glutathione by γ-glutamylcysteine ethyl ester protects mitochondria against peroxynitrite-induced oxidative stress. J Neurosci Res 74:917–927PubMedCrossRefGoogle Scholar
  23. 23.
    Butterfield DA, Castegna A, Pocernich CB, Drake J, Scapagnini G, Calabrese V (2002) Nutritional approaches to combat oxidative stress in Alzheimer’s disease. J Nutr Biochem 13:444–461PubMedCrossRefGoogle Scholar
  24. 24.
    Alam J, Cook JL (2003) Transcriptional regulation of the heme oxygenase-1 gene via the stress response element pathway. Curr Pharm Des 9:2499–2511PubMedCrossRefGoogle Scholar
  25. 25.
    Balogun E, Hoque M, Gong P, Killeen E, Green CJ, Foresti R, Alam J, Motterlini R (2003) Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J 371:887–895PubMedCrossRefGoogle Scholar
  26. 26.
    Poon F, Calabrese V, Scapagnini G, Butterfield DA (2004) Free radicals: key to brain aging and heme oxygenase as a cellular response to oxidative stress. J Gerontol A Biol Sci Med Sci 59:478–493PubMedGoogle Scholar
  27. 27.
    Calabrese V, Ravagna A, Colombrita C, Guagliano E, Scapagnini G, Calvani M, Butterfield DA, Giuffrida Stella AM (2005) Acetylcarnitine induces heme oxygenase in rat astrocytes and protects against oxidative stress: involvement of the transcription factor Nrf2. J Neurosci Res 79:509–521PubMedCrossRefGoogle Scholar
  28. 28.
    Calabrese V, Scapagnini G, Ravagna A, Colombrita C, Spadaro F, Butterfield DA, Giuffrida Stella AM (2004) Increased expression of heat shock proteins in rat brain during aging: relationship with mitochondrial function and glutathione redox state. Mech Ageing Dev 125:325–335PubMedCrossRefGoogle Scholar
  29. 29.
    Calabrese V, Testa D, Ravagna A, Bates TE, Giuffrida Stella AM (2000) Hsp70 induction in the brain following ethanol administration in the rat: regulation by glutathione redox state. Biochem Biophys Res Commun 269:397–400PubMedCrossRefGoogle Scholar
  30. 30.
    Poon HF, Calabrese V, Scapagnini G, Butterfield DA (2004) Free radicals and brain aging. Clin Geriatr Med 20:329–359PubMedCrossRefGoogle Scholar
  31. 31.
    Calabrese V, Scapagnini G, Colombrita C, Ravagna A, Pennisi G, Giuffrida Stella AM, Galli F, Butterfield DA (2003) Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach. Amino Acids 25:437–444PubMedCrossRefGoogle Scholar
  32. 32.
    Franklin TB, Krueger-Naug AM, Clarke DB, Arrigo AP, Currie RW (2005) The role of heat shock proteins Hsp70 and Hsp27 in cellular protection of the central nervous system. Int J Hyperthermia 21:379–392PubMedCrossRefGoogle Scholar
  33. 33.
    Igarashi K, Sun J (2006) The heme-bach1 pathway in the regulation of oxidative stress response and erythroid differentiation. Antioxid Redox Signal 8:107–118PubMedCrossRefGoogle Scholar
  34. 34.
    Mosser DD, Morimoto RI (2004) Molecular chaperones and the stress of oncogenesis. Oncogene 23:2907–2918PubMedCrossRefGoogle Scholar
  35. 35.
    Sultana R, Ravagna A, Mohmmad-Abdul H, Calabrese V, Butterfield DA (2005) Ferulic acid ethyl ester protects neurons against amyloid beta-peptide(1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity. J Neurochem 92:749–758PubMedCrossRefGoogle Scholar
  36. 36.
    Calabrese V, Scapagnini G, Ravagna A, Fariello RG, Giuffrida Stella AM, Abraham NG (2002) Regional distribution of heme oxygenase, HSP70, and glutathione in brain: relevance for endogenous oxidant/antioxidant balance and stress tolerance. J Neurosci Res 68:65–75PubMedCrossRefGoogle Scholar
  37. 37.
    Calabrese V, Bates TE, Giuffrida Stella AM (2000) NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders: the role of oxidant/antioxidant balance. Neurochem Res 25:1315–1341PubMedCrossRefGoogle Scholar
  38. 38.
    Joshi G, Perluigi M, Sultana R, Agrippino R, Calabrese V, Butterfield DA (2006) In vivo protection of synaptosomes by ferulic acid ethyl ester (FAEE) from oxidative stress mediated by 2,2-azobis(2-amidino-propane)dihydrochloride (AAPH) or Fe(2+)/H(2)O(2): insight into mechanisms of neuroprotection and relevance to oxidative stress-related neurodegenerative disorders. Neurochem Int 48:318–327PubMedCrossRefGoogle Scholar
  39. 39.
    Izaki K, Kinouchi H, Watanabe K, Owada Y, Okubo A, Itoh H, Kondo H, Tashima Y, Tamura S, Yoshimoto T, Mizoi K (2001) Induction of mitochondrial heat shock protein 60 and 10 mRNAs following transient focal cerebral ischemia in the rat. Brain Res Mol Brain Res 31:14–25CrossRefGoogle Scholar
  40. 40.
    Okubo A, Kinouchi H, Owada Y, Kunizuka H, Itoh H, Izaki K, Kondo H, Tashima Y, Yoshimoto T, Mizoi K (2000) Simultaneous induction of mitochondrial heat shock protein mRNAs in rat forebrain ischemia. Brain Res Mol Brain Res 84:127–134PubMedCrossRefGoogle Scholar
  41. 41.
    Maines MD (1997) The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37:517–554PubMedCrossRefGoogle Scholar
  42. 42.
    Maines MD (1981) Zinc-protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat. Biochim Biophys Acta 673:339–350PubMedGoogle Scholar
  43. 43.
    Mancuso C, Kostoglou-Athanassiou I, Forsling ML, Grossman AB, Preziosi P, Navarra P, Minotti G (1997) Activation of heme oxygenase and consequent carbon monoxide formation inhibits the release of arginine vasopressin from rat hypothalamic explants. Molecular linkage between heme catabolism and neuroendocrine function. Mol Brain Res 50:267–276PubMedCrossRefGoogle Scholar
  44. 44.
    Mancuso C (2004) Heme oxygenase and its products in the nervous system. Antioxid Redox Signal 6:878–887PubMedGoogle Scholar
  45. 45.
    Maines MD (1992) Heme oxygenase in clinical applications and functions. CRC Press, Boca RatonGoogle Scholar
  46. 46.
    Wang X, Hauptmann N, Taylor E, Foreman M, Khawli LA, Maines MD (2003) Neotrofin increases heme oxygenase-1 selectively in neurons. Brain Res 962:1–14PubMedCrossRefGoogle Scholar
  47. 47.
    Shibahara S (2003) The heme oxygenase dilemma in cellular homeostasis: new insights for the feedback regulation of heme catabolism. Tohoku J Exp Med 200:167–186PubMedCrossRefGoogle Scholar
  48. 48.
    Wu L, Wang R (2005) Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev 57:585–630PubMedCrossRefGoogle Scholar
  49. 49.
    Stocker R (2004) Antioxidant activities of bile pigments. Antioxid Redox Signal 6:841–849PubMedGoogle Scholar
  50. 50.
    Maines MD, Panahian N (2001) The heme oxygenase system and cellular defense mechanisms. Do HO-1 and HO-2 have different functions? Adv Exp Med Biol 502:249–272PubMedGoogle Scholar
  51. 51.
    Hill-Kapturczak N, Sikorski EM, Voakes C, Garcia J, Nick HS, Agarwal A (2003) An internal enhancer regulates heme and cadmium-mediated induction of human heme oxygenase-1. Am J Physiol Renal Physiol 285:F515–F523PubMedGoogle Scholar
  52. 52.
    Sun J, Hoshino O, Takaku K, Nakajima O, Muto A, Suzuki H, Tashiro S, Takahashi S, Shibahara S, Alam J, Taketo M, Yamamoto M, Igarashi K (2002) Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO J 21:5216–5224PubMedCrossRefGoogle Scholar
  53. 53.
    Stewart D, Killeen E, Naquin R, Alam S, Alam J (2003) Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium. J Biol Chem 278:2396–2402PubMedCrossRefGoogle Scholar
  54. 54.
    Scapagnini G, D’Agata V, Calabrese V, Pascale A, Colombrita C, Alkon D, Cavallaro S (2002) Gene expression profiles of heme oxygenase isoforms in the rat brain. Brain Res 954:51–59PubMedCrossRefGoogle Scholar
  55. 55.
    Ewing JF, Maines MD (1995) Immunohistochemical localization of biliverdin reductase in rat brain: age related expression of protein and transcript. Brain Res 672:29–41PubMedCrossRefGoogle Scholar
  56. 56.
    Maines MD, Trakshel GM (1993) Purification and characterization of human biliverdin reductase. Arch Biochem Biophys 300:320–326PubMedCrossRefGoogle Scholar
  57. 57.
    Ewing JF, Weber CM, Maines MD (1993) Biliverdin reductase is heat resistant and coexpressed with constitutive and heat shock forms of heme oxygenase in brain. J Neurochem 6:1015–1023CrossRefGoogle Scholar
  58. 58.
    Dwyer BE, Nishimura RN, Lu SY (1995) Differential expression of heme oxygenase-1 in cultured cortical neurons and astrocytes determined by the aid of a new heme oxygenase antibody. Response to oxidative stress. Mol Brain Res 30:37–47PubMedCrossRefGoogle Scholar
  59. 59.
    McCoubrey WK Jr, Huang TJ, Maines MD (1997) Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem 247:725–732PubMedCrossRefGoogle Scholar
  60. 60.
    Arnèr ESJ, Holmgren A (2000) Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 267:6102–6109PubMedCrossRefGoogle Scholar
  61. 61.
    Das KC (2005) Thioredoxin and its role in premature newborn biology. Antioxid. Redox Signal 7:1740–1743PubMedCrossRefGoogle Scholar
  62. 62.
    Cho CG, Kim HJ, Chung SW, Jung KJ, Shim KH, Yu BP, Yodoi J, Chung HY (2003) Modulation of glutathione and thioredoxin systems by calorie restriction during the aging process. Exp Gerontol 38:539–548PubMedCrossRefGoogle Scholar
  63. 63.
    Sun QA, Kirnarsky L, Sherman S, Gladyshev VN (2001) Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems. Proc Natl Acad Sci USA 98:3673–3678PubMedCrossRefGoogle Scholar
  64. 64.
    May JM, Morrow JD, Burk RF (2002) Thioredoxin reductase reduces lipid hydroperoxides and spares alpha-tocopherol. Biochem Biophys Res Commun 292:45–49PubMedCrossRefGoogle Scholar
  65. 65.
    Klotz LO, Sies H (2003) Defenses against peroxynitrite: selenocompounds and flavonoids. Toxicol Lett 140–141:125–132Google Scholar
  66. 66.
    Schweizer U, Brauer AU, Kohrle .J, Nitsch R, Savaskan NE (2004) Selenium and brain function: a poorly recognized liaison. Brain Res Brain Res Rev 45:164–178PubMedCrossRefGoogle Scholar
  67. 67.
    Venardos K, Harrison G, Headrick J, Perkins A (2004) Effects of dietary selenium on glutathione peroxidase and thioredoxin reductase activity and recovery from cardiac ischemia reperfusion. J Trace Elem Med Biol 18:81–88PubMedCrossRefGoogle Scholar
  68. 68.
    Richardson DR (2005) More roles for selenoprotein P: local selenium storage and recycling protein in the brain. J Biochem 386:5–7CrossRefGoogle Scholar
  69. 69.
    Jimenez A, Huikko MP, Gustafsson JA, Miranda-Vizuete A (2006) Characterization of human thioredoxin-like-1: potential involvement in the cellular response against glucose deprivation. FEBS Lett 580:960–967PubMedCrossRefGoogle Scholar
  70. 70.
    Patenaude A, Murthy MR, Mirault ME (2005) Emerging roles of thioredoxin cycle enzymes in the central nervous system. Cell Mol Life Sci 62:1063–1080PubMedCrossRefGoogle Scholar
  71. 71.
    Kim YC, Yamaguchi Y, Kondo N, Masutani H, Yodoi J (2003) Thioredoxin-dependent redox regulation of the antioxidant responsive element (ARE) in electrophile response. Oncogene 22:1860–1865PubMedCrossRefGoogle Scholar
  72. 72.
    Hirota K, Nakamura H, Masutani H, Yodoi J (2002) Thioredoxin superfamily and thioredoxin-inducing agents. Ann NY Acad Sci 957:189–199PubMedCrossRefGoogle Scholar
  73. 73.
    Biaglow JE, Miller RA (2005) The thioredoxin reductase/thioredoxin system: novel redox targets for cancer therapy. Cancer Biol Ther 4:6–13PubMedCrossRefGoogle Scholar
  74. 74.
    Bai J, Nakamura H, Kwon YW, Hattori I, Yamaguchi Y, Kim YC, Kondo N, Oka S, Ueda S, Masutani H, Yodoi J (2003) Critical roles of thioredoxin in nerve growth factor-mediated signal transduction and neurite outgrowth in PC12 cells. J Neurosci 23:503–509PubMedGoogle Scholar
  75. 75.
    Masutani H, Bai J, Kim YC, Yodoi J (2004) Thioredoxin as a neurotrophic cofactor and an important regulator of neuroprotection. Mol Neurobiol 29:229–242PubMedCrossRefGoogle Scholar
  76. 76.
    Trigona WL, Mullarky IK, Cao Y, Sordillo LM (2006) Thioredoxin reductase regulates the induction of heme oxygenase-1 expression in aortic endothelial cells. J Biochem 394:207–216CrossRefGoogle Scholar
  77. 77.
    Ryter SW, Alam J, Choi AM (2006) Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86:583–650PubMedCrossRefGoogle Scholar
  78. 78.
    Das KC, Das CK (2000) Thioredoxin, a singlet oxygen quencher and hydroxyl radical scavenger: redox independent functions. Biochem Biophys Res Commun 277:443–447PubMedCrossRefGoogle Scholar
  79. 79.
    Rhee SG, Kang SW, Chang TS, Jeong W, Kim K (2001) Peroxiredoxin, a novel family of peroxidases. IUBMB Life 52:35–41PubMedCrossRefGoogle Scholar
  80. 80.
    Krapfenbauer K, Engidawork E, Cairns N, Fountoulakis M, Lubecb G (2003) Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res 967:152–160PubMedCrossRefGoogle Scholar
  81. 81.
    Nonn L, Williams RR, Erickson RP, Powis G (2003) The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol. Cell. Biol. 23:916–922PubMedCrossRefGoogle Scholar
  82. 82.
    Chen Y, Cai J, Murphy TJ, Jones DP (2002) Overexpressed human mitochondrial thioredoxin confers resistance to oxidant-induced apoptosis in human osteosarcoma cells. J Biol Chem 277:33242–33248PubMedCrossRefGoogle Scholar
  83. 83.
    Rybnikova E, Damdimopoulos AE, Gustafsson JA, Spyrou G, Pelto-Huikko M (2000) Expression of novel antioxidant thioredoxin-2 in the rat brain. Eur J Neurosci 12:1669–1678PubMedCrossRefGoogle Scholar
  84. 84.
    Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, Thompson PM (2006) Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol 63:693–699PubMedCrossRefGoogle Scholar
  85. 85.
    Beere HM (2004) “The stress of dying”: the role of heat shock proteins in the regulation of apoptosis. J Cell Sci 117:2641–2651PubMedCrossRefGoogle Scholar
  86. 86.
    Sahara N, Murayama M, Mizoroki T, Urushitani M, Imai Y, Takahashi R, Murata S, Tanaka K, Takashima A (2005) In vivo evidence of CHIP up-regulation attenuating tau aggregation. J Neurochem 94:1254–1263PubMedCrossRefGoogle Scholar
  87. 87.
    Kosik KS, Shimura H (2005) Phosphorylated tau and the neurodegenerative foldopathies. Biochim Biophys Acta 1739:298–310PubMedGoogle Scholar
  88. 88.
    Fonte V, Kapulkin V, Taft A, Fluet A, Friedman D, Link CD (2002) Interaction of intracellular beta amyloid peptide with chaperone proteins. Proc Natl Acad Sci USA 99:9439–9444PubMedCrossRefGoogle Scholar
  89. 89.
    Wu Y, Luo Y (2005) Transgenic C. elegans as a model in Alzheimer’s research. Curr Alzheimer Res 2:37–45PubMedCrossRefGoogle Scholar
  90. 90.
    Magrane J, Smith RC, Walsh K, Querfurth HW (2004) Heat shock protein 70 participates in the neuroprotective response to intracellularly expressed beta-amyloid in neurons. J Neurosci 24:1700–1706PubMedCrossRefGoogle Scholar
  91. 91.
    Takahashi M, Dore S, Ferris CD, Tomita T, Sawa A, Wolosker H, Borchelt DR, Iwatsubo T, Kim SH, Thinakaran G, Sisodia SS, Snyder SH (2000) Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer’s disease. Neuron 28:461–473PubMedCrossRefGoogle Scholar
  92. 92.
    Premkumar DR, Smith MA, Richey PL, Petersen RB, Castellani R, Kutty RK, Wiggert B, Perry G, Kalaria RN (1995) Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer’s disease. J Neurochem 65:1399–1402PubMedCrossRefGoogle Scholar
  93. 93.
    Takeda A, Perry G, Abraham NG, Dwyer BE, Kutty RK, Laitinen JT, Petersen RB, Smith MA (2000) Overexpression of heme oxygenase in neuronal cells, the possible interaction with tau. J Biol Chem 275:5395–5399PubMedCrossRefGoogle Scholar
  94. 94.
    Schipper HM. (2000) Heme oxygenase-1: role in brain aging and neurodegeneration. Exp Gerontol 35:821–830PubMedCrossRefGoogle Scholar
  95. 95.
    Lovell MA, Xie C, Gabbita SP, Markesbery WR (2000) Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer’s disease brain. Free Radic Biol Med 28:418–427PubMedCrossRefGoogle Scholar
  96. 96.
    Calabrese V, Sultana R, Scapagnini G, Guagliano E, Sapienza M, Bella R, Kanski J, Pennisi G, Mancuso C, Giuffrida Stella AM, Butterfield DA (2006) Nitrosative stress, cellular stress response and thiol homeostasis in patients with Alzheimer’s disease. Antiox Redox Signal 8:1975–1986CrossRefGoogle Scholar
  97. 97.
    Calabrese V, Scapagnini G, Ravagna A, Bella R, Foresti R, Bates TE, Giuffrida Stella AM, Pennisi G (2002) Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in CSF protein nitrotyrosine, S-nitrosothiols and with changes in glutathione levels. J Neurosci Res 70:580–587PubMedCrossRefGoogle Scholar
  98. 98.
    Calabrese V, Butterfield DA, Giuffrida Stella AM (2003) Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer’s disease. It J Biochem 52:72–76Google Scholar
  99. 99.
    Scapagnini G, Butterfield DA, Colombrita C, Sultana R, Pascale A, Calabrese V (2004) Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rat neurons against oxidative stress. Antioxid Redox Signal 6:811–818PubMedGoogle Scholar
  100. 100.
    Scapagnini G, Foresti R, Calabrese V, Giuffrida Stella AM, Green CJ, Motterlini R (2002) Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Mol Pharmacol 61:554–561PubMedCrossRefGoogle Scholar
  101. 101.
    Motterlini R, Foresti R, Bassi R, Green CJ (2000) Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med 28:1303–1312PubMedCrossRefGoogle Scholar
  102. 102.
    Oyake T, Itoh K, Motohashi H, Hayashi N, Hoshino H, Nishizawa M, Yamamoto M, Igarashi K (1996) Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. Mol Cell Biol 16:6083–6095PubMedGoogle Scholar
  103. 103.
    Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21:8370–8377PubMedGoogle Scholar
  104. 104.
    Kanski J, Aksenova M, Stoyanova A, Butterfield DA (2002) Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure-activity studies. J Nutr Biochem 13:273–281PubMedCrossRefGoogle Scholar
  105. 105.
    Kim HS, Cho JY, Kim DH, Yan JJ, Lee HK, Suh HW, Song DK (2004) Inhibitory effects of long-term administration of ferulic acid on microglial activation induced by intracerebroventricular injection of beta-amyloid peptide(1-42) in mice. Biol Pharm Bull 27:120–121PubMedCrossRefGoogle Scholar
  106. 106.
    Calabrese V, Colombrita C, Scapagnini G, Calvani M, Giuffrida Stella AM, Butterfield DA (2006) Acetylcarnitine and cellular stress response: role in nutritional redox homeostasis and regulation of longevity genes. J Nutr Biochem17:73–88PubMedCrossRefGoogle Scholar
  107. 107.
    Calabrese V, Colombrita C, Sultana R, Scapagnini G, Calvani M, Butterfield DA, Giuffrida Stella AM (2006) Redox modulation of heat shock protein expression by acetylcarnitine in aging brain: relationship to antioxidant status and mitochondrial function. Antioxid Redox Signal 8:404–416PubMedCrossRefGoogle Scholar
  108. 108.
    Poon HF, Calabrese V, Calvani M, Butterfield DA (2006) Proteomics analyses of specific protein oxidation and protein expression in aged rat brain and its modulation by l-acetylcarnitine: insights into the mechanisms of action of this proposed therapeutic agent for CNS disorders associated with oxidative stress. Antioxid Redox Signal 8:381–394PubMedCrossRefGoogle Scholar
  109. 109.
    Huang TJ, McCoubrey WK Jr, Maines MD (2001) Heme oxygenase-2 interaction with metalloporphyrins: function of heme regulatory motifs. Antioxid Redox Signal 3:685–696PubMedCrossRefGoogle Scholar
  110. 110.
    Poon HF, Frasier M, Shreve N, Calabrese V, Wolozin B, Butterfield DA (2005) Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice––a model of familial Parkinson’s disease. Neurobiol Dis 18:492–498PubMedCrossRefGoogle Scholar
  111. 111.
    Hyun DH, Gray DA, Halliwell B, Jenner P (2004) Interference with ubiquitination causes oxidative damage and increased protein nitration: implications for neurodegenerative diseases. J Neurochem 90:422–430Google Scholar
  112. 112.
    Calabrese V, Butterfield DA, Scapagnini G, Giuffrida Stella AM, Maines MD (2006) Redox regulation of heat shock protein expression by signaling involving nitric oxide and carbon monoxide: relevance to brain aging, neurodegenerative disorders, and longevity. Antioxid Redox Signal 8:444–477PubMedCrossRefGoogle Scholar
  113. 113.
    Kim JR, Kwon KS, Yoon HW, Lee SR, Rhee SG (2002) Oxidation of proteinaceous cysteine residues by dopamine-derived H2O2 in PC12 Cells. Arch Biochem Biophys 397:414–423PubMedCrossRefGoogle Scholar
  114. 114.
    Kang SW, Rhee SG, Chang TS, Jeong W, Choi MH (2005) 2-Cys-peroxiredoxin function in intracellular signal transduction: therapeutic implications. Trends Mol Med 11:571–578PubMedCrossRefGoogle Scholar
  115. 115.
    Hoffmann JH, Linke K, Graf PC, Lilie H, Jakob U (2004) Identification of a redox-regulated chaperone network. Embo J 23:160–168PubMedCrossRefGoogle Scholar
  116. 116.
    Beckman JS, Carlson M, Smith CD, Koppenol WH (1993) ALS, SOD and peroxynitrite. Nature 364:584–586PubMedCrossRefGoogle Scholar
  117. 117.
    Heales SJR, Bolanos JP, Stewart VC, Brookes PS, Land JM, Clark JB (1999) Nitric oxide, mitochondria and neurological disease. Biochem Biophys Acta 1410:215–228PubMedCrossRefGoogle Scholar
  118. 118.
    Perluigi M, Fai Poon H, Hensley K, Pierce WM, Klein JB, Calabrese V, De Marco C, Butterfield DA (2005) Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice—A model of familial amyotrophic lateral sclerosis. Free Rad Biol Med 38:960–968PubMedCrossRefGoogle Scholar
  119. 119.
    Poon HF, Hensley K, Thongboonkerd V, Merchant ML, Lynn BC, Pierce WM, Klein JB, Calabrese V, Butterfield DA (2005) Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice––a model of familial amyotrophic lateral sclerosis. Free Radic Biol Med 39:453–462PubMedCrossRefGoogle Scholar
  120. 120.
    Lodi R, Tonon C, Calabrese V, Schapira AH (2006) Friedreich’s ataxia: from disease mechanisms to therapeutic interventions. Antioxid Redox Signal 8:438–443PubMedCrossRefGoogle Scholar
  121. 121.
    Perluigi M, Poon HF, Maragos W, Pierce WM, Klein JB, Calabrese V, Cini C, De Marco C, Butterfield DA (2005) Proteomic analysis of protein expression and oxidative modification in R6/2 transgenic mice: a model of Huntington disease. Mol Cel Proteomics 4:1849–1861CrossRefGoogle Scholar
  122. 122.
    Risch N, Merikangas K (1996) The future of genetic studies of complex human diseases. Science 273:1516–1517PubMedCrossRefGoogle Scholar
  123. 123.
    Calabrese V, Scapagnini G, Ravagna A, Bella R, Butterfield DA, Calvani M, Pennisi G, Giuffrida Stella AM (2003) Disruption of thiol homeostasis and nitrosative stress in the cerebrospinal fluid of patients with active multiple sclerosis: evidence for a protective role of acetylcarnitine. Neurochem Res 28:1321–1328PubMedCrossRefGoogle Scholar
  124. 124.
    Stamler JS, Hausladen A (1998) Oxidative modifications in nitrosative stress. Cell 78:931–936CrossRefGoogle Scholar
  125. 125.
    Carrell RW (2005) Cell toxicity and conformational disease. Trends Cell Biol 15:574–580PubMedCrossRefGoogle Scholar
  126. 126.
    Hayden MR, Tyagi SC, Kerklo MM, Nicolls MR (2005) Type 2 diabetes mellitus as a conformational disease. JOP 6:287–302PubMedGoogle Scholar
  127. 127.
    Cecchi C, Pensalfini A, Baglioni S, Fiorillo C, Caporale R, Formigli L, Liguri G, Stefani M (2006) Differing molecular mechanisms appear to underlie early toxicity of prefibrillar HypF-N aggregates to different cell types. FEBS J 273:2206–2222PubMedCrossRefGoogle Scholar
  128. 128.
    Abdul HM, Calabrese V, Calvani M, Butterfield DA (2006) Acetyl-l-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer’s disease. J Neurosci Res 84:398–408PubMedCrossRefGoogle Scholar
  129. 129.
    Anfinsen CB (1972) The formation and stabilization of protein structure. Biochem J 128:737–749PubMedGoogle Scholar
  130. 130.
    Qu K, Chen CP, Halliwell B, Moore PK, Wong PT (2006) Hydrogen sulfide is a mediator of cerebral ischemic damage. Stroke 37:889–893PubMedCrossRefGoogle Scholar
  131. 131.
    Calabrese V, Maines MD (2006) Antiaging medicine: antioxidants and aging. Antioxid Redox Signal 8:362–364PubMedCrossRefGoogle Scholar
  132. 132.
    Perluigi M, Joshi G, Sultana R, Calabrese V, De Marco C, Coccia R, Cini C, Butterfield DA (2006) In vivo protective effects of ferulic acid ethyl ester against amyloid-beta peptide 1-42-induced oxidative stress. J Neurosci Res 84:418–426PubMedCrossRefGoogle Scholar
  133. 133.
    Calabrese V, Scapagnini G, Giuffrida Stella AM, Bates TE, Clark JB (2001) Mitocondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disordes and longevity. Neurochem Res 26:739–764PubMedCrossRefGoogle Scholar
  134. 134.
    Calabrese V, Scapagnini G, Catalano C, Bates TE, Dirotta F, Micali G, Giuffrida Stella AM (2001) Induction of heat shock protein synthesis in human skin fibroblasts in response to oxidative stress: regulation by a natural antioxidant from rosemary extract. Int J Tissue React 23:121–128Google Scholar
  135. 135.
    Calabrese V, Raffaele R, Casentino E, Rizza V (1994) Changes in cerebrospinal fluid levels of malonaldehyde and glutathione reductase activity in multiple sclerosis. J Clin Pharmacol. Res 4:119–123Google Scholar
  136. 136.
    Calabrese V, Bella R, Testa D, Spadaro F, Scorfani A, Rizza V, Pennisi G (1998) Increased cerebrospinal fluid and plasma levels of ultraweak chemiluminescence are associated with changes in the thiol pool and lipid-soluble fluorescence in multiple sclerosis: The pathogenic role of oxidative stress. Drugs Exp Clin Res 24:125–131PubMedGoogle Scholar
  137. 137.
    Scapagnini G, Ravagna A, Bella R, Colombrita C, Pennisi G, Calvani M, Alkon D, Calabrese V (2002) Long-term ethanol administration enhances age-dependent modulation of redox state in brain and peripheral organs of rat: protection by acetyl carnitine. Int J Tissue React 24:89–96PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • Vittorio Calabrese
    • 1
  • Eleonora Guagliano
    • 1
  • Maria Sapienza
    • 1
  • Mariangela Panebianco
    • 1
  • Stella Calafato
    • 1
  • Edoardo Puleo
    • 1
  • Giovanni Pennisi
    • 2
  • Cesare Mancuso
    • 3
  • D. Allan Butterfield
    • 4
  • Annamaria Giuffrida Stella
    • 1
  1. 1.Section of Biochemistry and Molecular Biology, Department of Chemistry, Faculty of Medicine University of CataniaCataniaItaly
  2. 2.Department of Neurosciences, Faculty of Medicine University of CataniaCataniaItaly
  3. 3.Institute of PharmacologyCatholic University School of MedicineRomeItaly
  4. 4.Department of Chemistry, Sanders-Brown Center on Aging and Center of Membrane SciencesUniversity of KentuckyLexingtonUSA

Personalised recommendations